References

Unresolved reference

2026 · External reference

Low-doses of cisplatin injure hippocampal synapses: a mechanism for 'chemo' brain?

10.1016/j.expneurol.2014.02.020 · 2014 · External reference

Object recognition memory and the rodent hippocampus

10.1101/lm.1650110 · 2010 · External reference

Combined C-Reactive protein and novel inflammatory parameters as a predictor in cancer-what can we learn from the hematological experience?

10.3390/cancers12071966 · 2020 · External reference

Elevated C-Reactive protein and subsequent patient-reported cognitive problems in older breast cancer survivors: the thinking and living with cancer study

10.1200/jco.22.00406 · 2023 · External reference

Treatment response and cognitive impairment in major depression: association with C-reactive protein

10.1016/j.bbi.2011.07.239 · 2012 · External reference

Cognitive function and quality of life in ovarian cancer

10.1016/j.ygyno.2011.11.005 · 2012 · External reference

Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study

10.1007/s11682-016-9608-4 · 2017 · External reference

Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective study

10.1007/s00404-020-05896-6 · 2021 · External reference

Evaluating cell lines as tumour models by comparison of genomic profiles

10.1038/ncomms3126 · 2013 · External reference

Beyond genomics: critical evaluation of cell line utility for ovarian cancer research

10.1016/j.ygyno.2015.08.017 · 2015 · External reference

Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment

10.1016/j.cell.2018.10.049 · 2019 · External reference

Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer

10.1016/j.suponc.2010.09.028 · 2010 · External reference

Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology/gynecologic oncology group study

10.1016/j.ygyno.2015.10.003 · 2015 · External reference

The athymic nude rat. Immunobiological characteristics with special reference to establishment of non-antigen-specific T-cell reactivity and induction of antigen-specific immunity

1991 · External reference

Prevalence, mechanisms, and management of cancer-related cognitive impairment

10.3109/09540261.2013.864260 · 2014 · External reference

Detecting and discriminating novel objects: the impact of perirhinal cortex disconnection on hippocampal activity patterns

10.1002/hipo.22615 · 2016 · External reference

Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats

10.1016/j.freeradbiomed.2016.11.046 · 2017 · External reference

Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity

10.1016/j.expneurol.2024.114717 · 2024 · External reference

N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat model

10.1016/j.canlet.2024.217405 · 2025 · External reference

Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients

10.1016/j.bbi.2007.12.012 · 2008 · External reference

Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients

10.1016/j.ygyno.2013.09.025 · 2013 · External reference

Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients

10.1200/jco.2007.14.1978 · 2008 · External reference

Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer

10.1016/j.jneuroim.2016.11.002 · 2016 · External reference

Impact of psychological stress and spontaneous tumour regression on the hippocampal proteome in a mouse model of breast cancer

10.1111/jnc.70052 · 2025 · External reference

Tumour brain: pretreatment cognitive and affective disorders caused by peripheral cancers

10.1111/bph.15571 · 2021 · External reference

Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group

2021 · External reference

Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations

10.1007/s11682-013-9256-x · 2013 · External reference

Association of C-Reactive protein with cognitive impairment

10.1001/archneurol.2009.308 · 2010 · External reference

Decreased C-Reactive protein levels in alzheimer disease

10.1177/0891988709351832 · 2010 · External reference

Chemotherapy-related cognitive dysfunction and effects on quality of life in gynecologic cancer patients

2018 · External reference

High levels of C-Reactive protein are associated with an increased risk of ovarian cancer: results from the ovarian cancer Cohort consortium

10.1158/0008-5472.can-19-1554 · 2019 · External reference

A novel serous ovarian carcinoma model induced by DMBA: results from OncoTherad® (MRB-CFI-1) immunotherapy preclinical testing

10.1016/j.biopha.2024.117755 · 2025 · External reference

The athymic nude rat: an animal experimental model to reveal novel aspects of innate immune responses?

10.1034/j.1600-065x.2001.1840113.x · 2001 · External reference

Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents

10.1016/j.bbi.2015.04.010 · 2015 · External reference

Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats

10.1186/1757-2215-3-9 · 2010 · External reference

Selective Anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment

10.1097/aln.0b013e3182834d77 · 2013 · External reference

Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD)

10.1038/s41598-024-57922-1 · 2024 · External reference

Determination of subcutaneous tumor size in athymic (nude) mice

10.1007/bf00300234 · 1989 · External reference

The role of Myeloid-Derived suppressor cells (MDSC) in cancer progression

2016 · External reference

Low dose aspirin blocks breast cancer-induced cognitive impairment in mice

10.1371/journal.pone.0208593 · 2018 · External reference

The association between neuropsychological impairment, self-perceived cognitive deficit, symptoms, and health related quality of life in newly diagnosed ovarian cancer patients

10.1016/j.apjon.2024.100447 · 2024 · External reference

Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures

1990 · External reference

Prolonged anesthesia induces neuroinflammation and complement-mediated microglial synaptic elimination involved in neurocognitive dysfunction and anxiety-like behaviors

10.1186/s12916-022-02705-6 · 2023 · External reference

Cancer-related cognitive impairment: a practical guide for oncologists

10.1200/op-24-00953 · 2025 · External reference